The lab has a general interest in neurosynaptic signaling in neurological and psychiatric disorders. Our goal is to translate our lab research to development of new therapeutic interventions for disease treatment. Current projects include: 1)Noradrenergic signaling in Alzheimer’s disease; 2)Protein trafficking in Alzheimer’s disease; 3)Synaptic signaling in social behavior and autism spectrum disorders; 4) Novel genetic risk factors for ADHD.
Keywords - synaptic receptors, signaling, protein trafficking, ligand regulation, neurodegeneration, neuroprotection, Alzheimer's disease, cognition, mood disorders